歯学研究院の格口先生と、野村特任助教、乙黒技術職員、前仲センター長の共同研究の論文がCancer Med.に掲載されました
Suramin, screened from an approved drug library, inhibits HuR functions and attenuates malignant phenotype of oral cancer cells.
Cancer Medicine
Kakuguchi W, Nomura T, Kitamura T, Otsuguro S, Matsushita K, Sakaitani M, Maenaka K, Tei K.
2018 Nov 18. doi: 10.1002/cam4.1877. [Epub ahead of print]
PMID: 30449075
